Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PsOsim: CHS-1420 vs Humira in Chronic Plaque Psoriasis
NCT02489227Phase 3Completed
- Sponsor
- Coherus BioSciences, Inc.
- Start
- Aug 2015
- Primary completion
- May 2016
- Modality
- Monoclonal Antibodies
- Countries
- 16
01
Overview
A Phase 3 trial of adalimumab aqvh in plaque psoriasis, sponsored by Coherus BioSciences, Inc.. Started Aug 2015; status: completed.
02
Drugs
adalimumab aqvh
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02489227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02489227.